Clinical Trial Update: Effects of Levosimendan on Cardiac Function After TAVR in Patients With Heart Failure [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effects of levosimendan on cardiac function after transcatheter aortic valve replacement in patients with heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis
• Heart Failure

Drugs mentioned

• Levosimendan (levosimendan)

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: Heart Failure, Aortic Stenosis, Severe | Phase 4 | Status: UNKNOWN